category,datetime,headline,id,image,related,source,summary,url
company,1768240073,Jim Cramer Says “Cardinal Is Really the Monster” Among Drug Distributors,138076639,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MCK,Yahoo,"Cardinal Health, Inc. (NYSE:CAH) is one of the stocks from different market sectors that Jim Cramer commented on. Cramer highlighted the company’s noteworthy performance, as he commented: “The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman. Even the president doesn’t talk, like… them. But I got to […]",https://finnhub.io/api/news?id=8393446f81ca36c9afa07275d33c15d7d0a6033b79f962bc957e26691b516da5
company,1768235880,McKesson Corp. stock outperforms competitors on strong trading day,138128168,,MCK,MarketWatch,McKesson Corp. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=6c7678bc240979cd21a0bd884e8b2de8de9ebeac5d015c6cc90ceabb9a7cbaee
company,1768226400,AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies,138072438,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MCK,Yahoo,"John Kimmet General Manager of AOP Health US WILMINGTON, Del., Jan. 12, 2026 (GLOBE NEWSWIRE) -- AOP Health US, LLC announced today that Rapiblyk™ (landiolol) is now more widely available across the United States through Cardinal, Cencora Specialty Distribution, McKesson Corporation, and M&D Specialty Distribution. Hospitals and health systems nationwide can now access Rapiblyk™ through their preferred purchasing channels, enhancing flexibility while expanding the availability of this critical c",https://finnhub.io/api/news?id=61a3682e747fcea2e14081a95b95c4a99359957f36e8bd244046a10458c57eef
company,1768222260,3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds,138072439,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MCK,Yahoo,"Cardinal Health, McKesson, and Cencora are showing how scale, specialty focus, and execution can drive market-beating returns despite macro pressure.",https://finnhub.io/api/news?id=04627c1a3f44b1cfe36272e22f70e136a83168f003f99872972a09e914069a3a
